Samlyn Capital, LLC Bio Rad Laboratories, Inc. Transaction History

Samlyn Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $28.2 Million - $31.8 Million	-97,633 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$244.1 - $303.88 $19.8 Million - $24.7 Million	-81,167 Reduced 45.4%	97,633 $28.2 Million
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $9.48 Million - $11.1 Million	-40,519 Reduced 18.47%	178,800 $44.7 Million
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $22.6 Million - $28.3 Million	104,335 Added 90.74%	219,319 $52.3 Million
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $24.4 Million - $27.9 Million	114,984	114,984 $25.6 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.19B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.